|
Michael D. Casey is currently a Director of a number of biotechnology and pharmaceutical companies including Bone Care International Inc. Cholestech Corporation Sicor Inc. Allos Therapeutics and Celgene Corporation.
Mr. Casey has 36 years of pharmaceutical industry experience including 25 years of commercial experience at Johnson and Johnson companies where he served as the President of McNeil Pharmaceuticals during his last four years with the corporation. After leaving Johnson and Johnson Mr. Casey served as Chairman President and Chief Executive Officer of Genetic Therapy Inc. from 1993 until 1994 and served later as Chairman President and Chief Executive Officer of Matrix Pharmaceuticals from September 1997 until March of 2002. | 